Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction

Abstract Multi-organ fibrosis among end stage renal disease (ESRD) patients cannot be explained by uremia alone. Despite mitigation of thrombosis during hemodialysis (HD), subsequent platelet dysfunction and tissue dysregulation are less understood. We comprehensively profiled plasma and platelets f...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Aaron J. Velasquez-Mao, Mark A. Velasquez, Zhengxiong Hui, Denise Armas-Ayon, Jingshen Wang, Moriel H. Vandsburger
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4b0723b32a1342b4a390eadbc03000a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4b0723b32a1342b4a390eadbc03000a0
record_format dspace
spelling oai:doaj.org-article:4b0723b32a1342b4a390eadbc03000a02021-12-02T18:25:03ZHemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction10.1038/s41598-021-91416-82045-2322https://doaj.org/article/4b0723b32a1342b4a390eadbc03000a02021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91416-8https://doaj.org/toc/2045-2322Abstract Multi-organ fibrosis among end stage renal disease (ESRD) patients cannot be explained by uremia alone. Despite mitigation of thrombosis during hemodialysis (HD), subsequent platelet dysfunction and tissue dysregulation are less understood. We comprehensively profiled plasma and platelets from ESRD patients before and after HD to examine HD-modulation of platelets beyond thrombotic activation. Basal plasma levels of proteolytic regulators and fibrotic factors were elevated in ESRD patients compared to healthy controls, with isoform-specific changes during HD. Platelet lysate (PL) RNA transcripts for growth and coagulative factors were elevated post-HD, with upregulation correlated to HD vintage. Platelet secretome correlations to plasma factors reveal acutely induced pro-fibrotic platelet phenotypes in ESRD patients during HD characterized by preferentially enhanced proteolytic enzyme translation and secretion, platelet contribution to inflammatory response, and increasing platelet dysfunction with blood flow rate (BFR) and Vintage. Compensatory mechanisms of increased platelet growth factor synthesis with acute plasma matrix metalloproteinase (MMP) and tissue inhibitor of MMPs (TIMP) increases show short-term mode-switching between dialysis sessions leading to long-term pro-fibrotic bias. Chronic pro-fibrotic adaptation of platelet synthesis were observed through changes in differential secretory kinetics of heterogenous granule subtypes. We conclude that chronic and acute platelet responses to HD contribute to a pro-fibrotic milieu in ESRD.Aaron J. Velasquez-MaoMark A. VelasquezZhengxiong HuiDenise Armas-AyonJingshen WangMoriel H. VandsburgerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Aaron J. Velasquez-Mao
Mark A. Velasquez
Zhengxiong Hui
Denise Armas-Ayon
Jingshen Wang
Moriel H. Vandsburger
Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
description Abstract Multi-organ fibrosis among end stage renal disease (ESRD) patients cannot be explained by uremia alone. Despite mitigation of thrombosis during hemodialysis (HD), subsequent platelet dysfunction and tissue dysregulation are less understood. We comprehensively profiled plasma and platelets from ESRD patients before and after HD to examine HD-modulation of platelets beyond thrombotic activation. Basal plasma levels of proteolytic regulators and fibrotic factors were elevated in ESRD patients compared to healthy controls, with isoform-specific changes during HD. Platelet lysate (PL) RNA transcripts for growth and coagulative factors were elevated post-HD, with upregulation correlated to HD vintage. Platelet secretome correlations to plasma factors reveal acutely induced pro-fibrotic platelet phenotypes in ESRD patients during HD characterized by preferentially enhanced proteolytic enzyme translation and secretion, platelet contribution to inflammatory response, and increasing platelet dysfunction with blood flow rate (BFR) and Vintage. Compensatory mechanisms of increased platelet growth factor synthesis with acute plasma matrix metalloproteinase (MMP) and tissue inhibitor of MMPs (TIMP) increases show short-term mode-switching between dialysis sessions leading to long-term pro-fibrotic bias. Chronic pro-fibrotic adaptation of platelet synthesis were observed through changes in differential secretory kinetics of heterogenous granule subtypes. We conclude that chronic and acute platelet responses to HD contribute to a pro-fibrotic milieu in ESRD.
format article
author Aaron J. Velasquez-Mao
Mark A. Velasquez
Zhengxiong Hui
Denise Armas-Ayon
Jingshen Wang
Moriel H. Vandsburger
author_facet Aaron J. Velasquez-Mao
Mark A. Velasquez
Zhengxiong Hui
Denise Armas-Ayon
Jingshen Wang
Moriel H. Vandsburger
author_sort Aaron J. Velasquez-Mao
title Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
title_short Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
title_full Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
title_fullStr Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
title_full_unstemmed Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
title_sort hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4b0723b32a1342b4a390eadbc03000a0
work_keys_str_mv AT aaronjvelasquezmao hemodialysisexacerbatesproteolyticimbalanceandprofibroticplateletdysfunction
AT markavelasquez hemodialysisexacerbatesproteolyticimbalanceandprofibroticplateletdysfunction
AT zhengxionghui hemodialysisexacerbatesproteolyticimbalanceandprofibroticplateletdysfunction
AT denisearmasayon hemodialysisexacerbatesproteolyticimbalanceandprofibroticplateletdysfunction
AT jingshenwang hemodialysisexacerbatesproteolyticimbalanceandprofibroticplateletdysfunction
AT morielhvandsburger hemodialysisexacerbatesproteolyticimbalanceandprofibroticplateletdysfunction
_version_ 1718378038988636160